Eichhorn, W; Egle, U; Buchholz, H-G et al.
Neuronal correlates of overt hypothyroidism measured by FDG PETJ Nucl Med. 2007 S. 272
Dittmar, M; Bischofs, C; Kanitz, M et al.
Novel mutations in the DNase gene are associated with decreased DNase activity in thyroid autoimmunityAnnual Meeting of the American Thyroid Association, New York City, October 2007Thyroid. Bd. 17. H. sup1. 2007 S. pp79
Gockel, I; Schimanski, CC; Moehler, M et al.
Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4.Future Oncol. Bd. 3. H. 2. 2007 S. 119-22
Knapp, W; Kahaly, GJ
Nuklearmedizinische und endokrinologische Nachsorge des Schilddrüsenkarzinoms – Modernes NachsorgekonzeptKassenarzt. Bd. 11. 2007 S. 22 - 29
Grigorescu Sido, P; Drugan, C; Cret, V et al.
Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience.J Inherit Metab Dis. Bd. 30. H. 5. 2007 S. 783-9
Horke, S; Witte, I; Wilgenbus, P et al.
Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation.Circulation. Bd. 115. H. 15. 2007 S. 2055-64
Pfutzner, A; Weber, MM; Forst, T
Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.Expert Opin Pharmacother. Bd. 8. H. 12. 2007 S. 1985-98
Ide, M; Dittmar, M; Wurm, M et al.
Polymorphismen des MICA-Mikrosatelliten bei thyreoidaler Autoimmunitat.Med Klin (Munich). Bd. 102. H. 1. 2007 S. 11-5
Eckert, S; Erdmann, E; Lundershausen, R et al.
Positionsbestimmung zum Stellenwert von Pioglitazon in der Diabetestherapie.Deut Med Wochenschr. Bd. 132. 2007 S. 2650-2653
Helisch, A; Fottner, C; Reber, H et al.
Pre-therapeutic dosimetry of metastatic neuroendocrine tumors: Implicatons for peptide receptor radiotherapyeingereicht. 2007 S. 1-